Modeling of bone formation and resorption mediated by parathyroid hormone: Response to estrogen/PTH therapy

BioSystems

Volumn 70, Issue 1, 2003, Pages 55-72

  Rattanakul, Chontita ^a   Lenbury, Yongwimon ^a   Krishnamara, Nateetip ^a   Wollkind, David J ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Bone remodeling; Estrogen therapy; Parathyroid hormone control

Indexed keywords

CALCIUM; ESTROGEN; PARATHYROID HORMONE;

BIOLOGY; BONE;

ARTICLE; BONE; BONE GROWTH; BONE REMODELING; BONE TURNOVER; ESTROGEN THERAPY; HORMONAL REGULATION; HORMONAL THERAPY; HORMONE ACTION; MATHEMATICAL MODEL; NONLINEAR SYSTEM; OSSIFICATION; OSTEOLYSIS;

EID: 0038738223     PISSN: 03032647     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-2647(03)00040-6     Document Type: Article

References (40)

1. Albright F., Smith P.H., Richardson A.M. Postmenopausal osteoporosis. JAMA. 116:1941;2465-2474.
2. Albright, J.A., Sauders, M., 1990. The Scientific Basis of Orthopaedics. Appleton & Lange, Norwalk, CT.
3. Brabant G., Prank K., Schofl C. Pulsatile patterns in hormone secretion. Trends Endocrinol. Metab. 3:1992;183-190.
4. 2+ and other ions as extracellular (first) messengers. Physiol. Rev. 71:1991;371-411.
5. Burgess T.L., Qian Y., Kaufman S., Ring B.D., Van G., Capparelli C., Kelly M., Hsu H., Boyle W.J., Dunstan C.R., Hu S., Lacey D.L. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J. Cell Biol. 145:1999;527-538.
6. DeCherney A. Physiologic and pharmacologic effects of estrogen and progestins on bone. J. Reprod. Med. 38(Suppl. 12):1993;1007-1014.
7. Dempster D.W., Cosman F., Parisisen M., Shen V., Linsay R. Anabolic actions of parathyroid hormone on bone. Endocr. Rev. 14:1993;690-709.
8. Eckhaus, W., 1979. Asymptotic analysis of singular perturbation. North-Holland, Amsterdam.
9. Goldbeter, A., Li, Y.X., 1989. In: Goldbeter, A. (Ed.), Cell to Cell Signalling: From Experiments to Theoretical Models. Academic Press, London.
10. Harms H.M., Kaptaina U., Kulpmann W.R., Brabant G., Hesch R.D. Pulse amplitude and frequency modulation of parathyroid hormone in plasma. J. Clin. Endocrinol. Metab. 69(4):1989;843-851.
11. Heersche, J.N.M., Cherk, S., 1989. Metabolic Bone Disease: Cellular and Tissue Mechanisms. CRC Press, Boca Raton.
12. Heesterbeek J.A.P., Robert M.G. Threshold quantities for helminth infections. J. Math. Biol. 33(4):1995;415-434.
13. Hock J.M., Gera I. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J. Bone Miner. Res. 7(1):1992;65-72.
14. Hock, J.M., Fitzpatrick, L.A., Bilezikian, J.P., 2002. Principle of Bone Biology, vol. 1, 2nd ed. Academic Press, London.
15. Isogai Y.T., Akatsu T., Ishizuya T., Yamaguchi A., Hori M., Tokahashi N., Suda T. Parathyroid hormone regulates osteoblast differentiation positively or negatively depending on differentiation stages. J. Bone Miner. Res. 11:1996;1384-1393.
16. Jones C.K.R.T. Geometric singular perturbation theory. Dyn. Syst. Montecatibi Terme Lect. Notes Math. 1609:1994;44-118.
17. Kaper, T.J., 1999. An introduction to geometric methods and dynamical systems theory for singular perturbation problems. Analyzing multiscale phenomena using singular perturbation methods. In: Cronin, J., O'Malley Jr., R.E. (Eds.), Proceedings of the Symposia on Applied Mathematics, vol. 56. American Mathematical Society.
18. Kong Y.Y., Yoshida H., Sarosi I., Tan H.L., Timms E., Capparelli C., Morony S., Santos A., Van G., Itie A., Khoo W., Wakeham A., Dunstan C., Lacey D., Mak T., Boyle W., Penninger J. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 397:1999;315-323.
19. Kroll M.H. Parathyroid hormone temporal effects on bone formation and resorption. Bull. Math. Bio. 62:2000;163-188.
20. Leah, E.K., 1988. Mathematical Models in Biology. Random House, New York.
21. Lenbury Y., Kumnungkit K., Novaprateep B. Detection of slow-fast limit cycles in a model for electrical activity in the pancreatic β-cell. IMA. J. Maths. Appl. Med. Biol. 133(1):1997;49-97.
22. Marcus, R., 1994. Osteoporosis. Blackwell Scientific Publication, Oxford.
23. Momsen G., Schwarz P. A mathematical/physiological model of parathyroid hormone secretion in response to blood-ionized calcium lowering in vivo. Scand. J. Clin. Lab. Invest. 57:1997;381-394.
24. Moon L.Y., Wakley G.K., Turner R.T. Dose-dependent effects of tamoxifen on long bones in growing rats: Influence of ovarain status. Endocrinology. 129:1991;1568-1574.
25. Muratori S., Rinaldi S. Low- and high-frequency oscillations in three-dimensional food chain systems. Siam. J. Appl. Math. 52:1992;1688-1706.
26. Muse K.N., Manolagas S.C., Deftos L.J., Alexander N., Yen S.S.C. Calcium-regulating hormones across the menstrual cycle. J. Clin. Endocrinol. Metab. 62(2):1986;1313-1315.
27. O'Malley Jr., R.E., 1974. Introduction to Singular Perturbations. Academic Press, London.
28. Osipove, A.V., Soderbacka, G., Eirold, T., 1986. On the existence of positive periodic solutions in a dynamical system of two predator-one prey type. Viniti Deponent No. 4305-B4386 (in Russian).
29. Prank K., Harms H., Dammig M., Brabant G., Mitschke F., Hesch R.D. Is there is low-dimensional chaos in pulsatile secretion of parathyroid hormone in normal human subjects? Am. J. Physiol. 266:1994;E653-E658.
30. Prank K., Harms H., Brabant G., Hesch R.D. Nonlinear dynamics in pulsatile secretion of parathyroid hormone in normal human subjects. Chaos. 5:1995;76-81.
31. Prestwood K.M., Pilbeam C.C., Burleson J.A., Woodiel F.N., Delmas P.D., Deftos L.J., Raisz L.G. The short-term effects of conjugated estrogen on bone turnover in older women. J. Clin. Endocrinol. Metab. 79:1994;366-371.
32. Robert M.G., Kao R.R. The dynamics of an infectious disease in a population with birth pulses. Math. Biosci. 149:1998;23-36.
33. Schecter S. Persistence unstable equilibria and closed orbits of a singularly perturbed equation. J. Diff. Equas. 60:1985;131-141.
34. Schmitt C.P., Schaefer F., Bruch A., Veldhuis J.D., Gayk H.S., Stein G., Ritz E., Mehls O. Control of pulsatile and tonic parathyroid hormone secretion by ionized calcium. J. Clin. Endocrinol. Metab. 81:1996;4236-4243.
35. Takahashi N., Udagawa N., Suda T. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem. Biophys. Res. Commun. 256:1999;449-455.
36. Tam C.S., Heersche J.N.M., Murray T.M., Parsons J.A. Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration. Endocrinology. 110(2):1982;506-512.
37. Turner R.T., Lawrence B.R., Thomas C.S. Skeletal effects of estrogen. Endocr. Rev. 15(3):1994;275-300.
38. Veldhuis J.D. Nature of altered pulsatile hormone release and neuroendocrine network signaling in human ageing: clinical studies of the somatotropic, gonadotropic, corticotropic and insulin axes. Novartis Found. Symp. 227:2000;163-189.
39. Weryha G., Leclere J. Paracrine regulation of bone remodeling. Horm. Res. 43:1995;69-75.
40. Whitfield, J.F., Morley, P., Willick, G.E., 1998. The parathyroid hormone: an unexpected bone builder for treating osteoporosis. Landes Bioscience Company, Austin, Tex.